Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Humanin is a novel regula… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment

Artikel i vetenskaplig tidskrift
Författare F. Zaman
Y. H. Zhao
B. Celvin
H. H. Mehta
J. X. Wan
D. Chrysis
Claes Ohlsson
B. Fadeel
P. Cohen
L. Savendahl
Publicerad i Faseb Journal
Volym 33
Nummer/häfte 4
Sidor 4962-4974
ISSN 0892-6638
Publiceringsår 2019
Publicerad vid Centre for Bone and Arthritis Research
Sidor 4962-4974
Språk en
Länkar dx.doi.org/10.1096/fj.201801741R
Ämnesord glucocorticoids, inflammation, chondrocytes, apoptosis, indian hedgehog, proliferative chondrocytes, neuroprotective factor, apoptosis, cell, dexamethasone, activation, plate, differentiation, disease, Biochemistry & Molecular Biology, Life Sciences & Biomedicine - Other, Topics, Cell Biology, kigawa m, 1989, cancer research, v49, p3996
Ämneskategorier Cancer och onkologi

Sammanfattning

Glucocorticoids (GCs) are frequently used to treat chronic disorders in children, including inflammation and cancer. Prolonged treatment with GCs is well known to impair bone growth, an effect linked to increased apoptosis and suppressed proliferation in growth plate chondrocytes. We hypothesized that the endogenous antiapoptotic protein humanin (HN) may prevent these effects. Interestingly, GC-induced bone growth impairment and chondrocyte apoptosis was prevented in HN overexpressing mice, HN-treated wild-type mice, and in HN-treated cultured rat metatarsal bones. GC-induced suppression of chondrocyte proliferation was also prevented by HN. Furthermore, GC treatment reduced Indian Hedgehog expression in growth plates of wild-type mice but not in HN overexpressing mice or HN-treated wild-type animals. A Hedgehog (Hh) antagonist, vismodegib, was found to suppress the growth of cultured rat metatarsal bones, and this effect was also prevented by HN. Importantly, HN did not interfere with the desired anti-inflammatory effects of GCs. We conclude that HN is a novel regulator of Hh signaling preventing GC-induced bone growth impairment without interfering with desired effects of GCs. Our data may open for clinical studies exploring a new possible strategy to prevent GC-induced bone growth impairment by cotreating with HN.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?